AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2015
May 12, 2015
31523_dirs_2015-05-12_29c3566d-ea15-4810-8b9d-aca101d6b0aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-05-08
Reporting Person: Valenzano Ken (SVP, Pharmacology & Biology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-08 | Common stock | M | 25000 | — | Acquired | 25000 | Direct |
| 2015-05-08 | Common stock | F | 9313 | $10.80 | Disposed | 15687 | Direct |
| 2015-05-11 | Common stock | S | 5000 | $10.8399 | Disposed | 10687 | Direct |
| 2015-05-11 | Common stock | S | 8000 | $10.8513 | Disposed | 2687 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-08 | Restricted stock units | $ | M | 25000 | Disposed | Common Stock (25000) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2014.
F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.7262 to $10.95. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: The sale of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
F5: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.73 to $10.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6: On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.